24 commercial payer policies list J7171. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
24 policies from 14 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J7171 |
|---|---|---|
| Adzynma (ADAMTS13, Recombinant-Krhn) | Jul 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Jul 1, 2026 | Covered |
| Adzynma (ADAMTS13, Recombinant-Krhn) – Commercial and Individual Exchange Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title |
| Adzynma (ADAMTS13, Recombinant-Krhn) – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J7171 |
|---|---|---|
| Adzynma (ADAMTS13 recombinant-krhn) | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Adzynma (ADAMTS13 recombinant-krhn)Effective 04/01/2024 - 03/31/2025 | Apr 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Adzynma (ADAMTS13 recombinant-krhn)Effective 04/01/2025 - 03/31/2026 | Apr 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| Adzynma (ADAMTS13, recombinantkrhn) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Adzynma (ADAMTS13, recombinantkrhn) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Adzynma (ADAMTS13, recombinantkrhn) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| ADAMTS13, recombinant-krhn (Adzynma) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| ADAMTS13, recombinant-krhn (Adzynma) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| ADAMTS13, recombinant-krhn (Adzynma) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| ADAMTS13, recombinant-krhn (Adzynma) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| Adzynma (ADAMTS13, Recombinant-Krhn) | Jul 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J7171 |
|---|---|---|
| ADAMTS13, recombinant-krhn (e.g., Adzynma) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| ADZYNMA (ADAMTS13, RECOMBINANT-KRHN) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| ADAMTS13, recombinant-krhn (Adzynma) | Mar 1, 2024 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| ADAMTS13, Recombinant-krhn) (Adzynma); CP.PHAR.635 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| ADAMTS13, recombinant-krhn (Adzynma) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| 00887 ADAMTS13, recombinant-krhn (Adzynma) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| Adzynma (ADAMTS13, recombinant-krhn) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7171 |
|---|---|---|
| Adzynma (ADAMTS13, Recombinant-Krhn) | Jul 1, 2026 | Covered |